Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Status:
Recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
This is a randomised, double-blind, placebo-controlled, proof of clinical principle study to
explore the efficacy and safety of orally administered BBT-401-1S in subjects with ulcerative
colitis.